Pfiz­er preps new hires as it be­gins build­ing a $200M R&D cam­pus

Pfiz­er will be hir­ing around 80 new staffers for its new R&D cam­pus now un­der con­struc­tion — and this one is far from the two big hubs in the Bay Area and Boston/Cam­bridge that have proved so at­trac­tive to Big Phar­ma and biotech alike.

Pfiz­er $PFE will be bring­ing to­geth­er 450 R&D staffers and adding its new ros­ter in Chester­field, MO — a St. Louis sub­urb — once they com­plete work on the $200 mil­lion project now un­der­way. They’ll be work­ing on new drugs that fig­ure promi­nent­ly on core fields in Pfiz­er’s pipeline: on­col­o­gy, rare dis­ease, in­ter­nal med­i­cine, in­flam­ma­tion & im­munol­o­gy, and vac­cines, in­clud­ing biosim­i­lars, which Pfiz­er has been fo­cus­ing on since its Hos­pi­ra buy­out. And you can look for new work on man­u­fac­tur­ing process­es and dosage forms.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.